Globus Medical Inc  

(Public, NYSE:GMED)   Watch this stock  
Find more results for GMED
24.30
-0.07 (-0.29%)
Dec 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 24.17 - 24.50
52 week 17.45 - 27.14
Open 24.38
Vol / Avg. 151,728.00/500,398.00
Mkt cap 2.30B
P/E 27.01
Div/yield     -
EPS 0.90
Shares 94.48M
Beta     -
Inst. own 61%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 19.58% 15.79%
Operating margin 29.65% 23.40%
EBITD margin - 33.46%
Return on average assets 14.63% 13.54%
Return on average equity 17.10% 15.98%
Employees 850 -
CDP Score - -

Address

2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403
United States - Map
+1-610-9301800 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. As of December 31, 2011, the Company had launched over 110 products and offers a portfolio of products addressing a range of spinal pathologies, anatomies and surgical approaches. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company's Innovative Fusion products address a range of spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. In July 2012, the Company acquired the assets of a small company with operations in the United States and Germany, including a new product designed to treat vertebral compression fractures (VCFs). In January 2014, Globus Medical Inc acquired Excelsius Surgical.

Officers and directors

David C. Paul Chairman of the Board, Chief Executive Officer
Age: 47
Bio & Compensation  - Reuters
David M. Demski President, Chief Operating Officer, Director
Age: 56
Bio & Compensation  - Reuters
A. Brett Murphy Executive Vice President, US Sales
Age: 49
Bio & Compensation  - Reuters
David D. Davidar Senior Vice President - Operations , Director
Age: 48
Bio & Compensation  - Reuters
Steven M. Payne Chief Accounting Officer
Age: 43
Bio & Compensation  - Reuters
Daniel T. Lemaitre Independent Director
Age: 60
Bio & Compensation  - Reuters
Robert W. Liptak Independent Director
Age: 50
Bio & Compensation  - Reuters
Ann D. Rhoads Independent Director
Age: 48
Bio & Compensation  - Reuters
Kurt C. Wheeler Independent Director
Age: 61
Bio & Compensation  - Reuters